🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, randomised, open-label, 3-arm, multicentre, internatio...
Status
Recruiting
Location
Research Site
Start Date
2023-11-23
Trial ID
NCT06103864
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, and dose-expansion, with a ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-11-06
Trial ID
NCT04104672
Treatments Being Tested
This trial is a phase II clinical trial of the safety and efficacy of PD-1 ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-06-01
Trial ID
NCT06359275
Treatments Being Tested
The study is a prospective and observational cohort study. The purpose is t...
Status
Unknown
Location
Frist Affliated Hospital of Sun Yat-sen University
Start Date
2020-04-01
Trial ID
NCT04365049
Treatments Being Tested
A single-arm, interventional study combining Immunotherapy and propranolol ...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2023-07-05
Trial ID
NCT05451043
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of NALIRINO...
Status
Recruiting
Location
FirstNanjingMU
Start Date
2024-04-01
Trial ID
NCT06494514
Treatments Being Tested
1. Clinical evaluation of multimodal ablation system for pancreatic cancer ...
Status
Recruiting
Location
Shanghai General Hospital
Start Date
2023-10-08
Trial ID
NCT06307080
Treatments Being Tested
This study is a multicenter, open-label, phase II study to evaluate the saf...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-05-25
Trial ID
NCT05859750
This is a phase I/II, multi-center, open-label study of YH003 in combinatio...
Status
Completed
Location
Linear Clinical Research
Start Date
2020-08-04
Trial ID
NCT04481009
Treatments Being Tested
A Phase 1, first-in-human, monotherapy and combination dose escalation and ...
Status
Completed
Location
City of Hope
Start Date
2020-03-16
Trial ID
NCT04336098
Treatments Being Tested